3 news items
FDA Approves Baxter's Clinolipid Neonatal And Pediatric Indication
BAX
13 May 24
Baxter's continued commitment to meeting the diverse nutritional needs of patients, from preterm neonates to adults
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
BAX
13 May 24
demonstrates Baxter's continued commitment to meeting the diverse nutritional needs of patients, from preterm neonates to adults
Assessing Baxter Intl: Insights From 4 Financial Analysts
BAX
3 Apr 24
) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent
- Prev
- 1
- Next